ProteinQure raises $11M in Series A funding, led by Tom Williams of Heron Rock Fund, to support its first clinical trial for PQ203 and advance pipeline programs.
Amount Raised
$11 Million
Round Type
Series A
TorontoBiotechnologyHealth CareTherapeuticsInvestors
Description
ProteinQure, a Toronto-based biotechnology company, has closed $11M in Series A financing. The funding will support the initiation of its first clinical trial for PQ203 and advance additional pipeline programs in neurology and nephrology. The round was led by Tom Williams of Heron Rock Fund, with participation from Golden Ventures and Kensington Capital. This funding brings the total amount raised to $16M.
Quick answer
ProteinQure raised $11 Million in a Series A round, dated May 28, 2025. Investors: Golden Ventures, Kensington Capital, Tom Williams and Heron Rock Fund. ProteinQure is based in Toronto, Ontario, Canada.
- How much did ProteinQure raise?
- ProteinQure raised $11 Million in a Series A round on May 28, 2025.
- Who invested in ProteinQure?
- Golden Ventures, Kensington Capital, Tom Williams and Heron Rock Fund are named as investors in this round.
- What does ProteinQure do?
- ProteinQure is a biotechnology company developing computational peptide therapeutics.
- Where is ProteinQure based and how big is it?
- ProteinQure is based in Toronto, Ontario, Canada. Fundz records about 32 employees.
- Who are the decision-makers at ProteinQure?
- Fundz holds 2 contacts at ProteinQure. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as ProteinQure that raised within 45 days of this round, from Fundz verified event records.
- Renasant Bio raised $55M (Seed) on July 10, 2025.
- Nuclidium raised $98M (Series B) on July 10, 2025.
- CoRegen raised $93M (Funding Round) on July 9, 2025.
- BioSapien raised $8M (Pre-Series A) on July 7, 2025.
- FELIQS raised $9M (Series A) on July 1, 2025.
- Pelthos Therapeutics raised $50M on July 1, 2025.
Who to call at ProteinQure, and when
A new round usually means ProteinQure is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ProteinQure raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ProteinQure, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ProteinQure. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ProteinQure raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansProteinQure raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.